Last Updated: October 1, 2026

Ptc Therap Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PTC THERAP

PTC THERAP has three approved drugs.

There are four US patents protecting PTC THERAP drugs.

Summary for Ptc Therap

US Patents:	4
Tradenames:	2
Ingredients:	2
NDAs:	3

Drugs and US Patents for Ptc Therap

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ptc Therap	SEPHIENCE	sepiapterin	POWDER;ORAL	219666-002	Jul 28, 2025		RX	Yes	Yes	12,213,982	⤷ Start Trial				⤷ Start Trial
Ptc Therap	SEPHIENCE	sepiapterin	POWDER;ORAL	219666-001	Jul 28, 2025		RX	Yes	No	12,257,252	⤷ Start Trial				⤷ Start Trial
Ptc Therap	SEPHIENCE	sepiapterin	POWDER;ORAL	219666-001	Jul 28, 2025		RX	Yes	No		⤷ Start Trial				⤷ Start Trial
Ptc Therap	SEPHIENCE	sepiapterin	POWDER;ORAL	219666-001	Jul 28, 2025		RX	Yes	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Ptc Therap Drugs

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Japan	2021525746	⤷ Start Trial
Poland	3801534	⤷ Start Trial
Japan	2024178188	⤷ Start Trial
Lithuania	3801534	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for Ptc Therap Drugs

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
3801534	CA 2026 00028	Denmark	⤷ Start Trial	PRODUCT NAME: SEPIAPTERIN ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/25/1939 20250625
3801534	C20265018	Finland	⤷ Start Trial
3801534	301382	Netherlands	⤷ Start Trial	PRODUCT NAME: SEPIAPTERINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/25/1939 20250625
3801534	2026C/726	Belgium	⤷ Start Trial	PRODUCT NAME: SEPIAPTERINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: EU/1/25/1939 20250625
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Ptc Therap

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.